The aim of this study was to investigate the efficacy, safety, and acceptability of low-dose
mifepristone combined with self-administered misoprostol for ultra-early medical abortion. A …

Objectives. Medical abortion was first introduced in Norway in April 1998. The aims of this
study were to assess the efficacy, side effects, and acceptability of medical abortion using …

Objective Simultaneous mifepristone 200 mg and vaginal misoprostol 800 μg produces a
complete abortion rate of approximately 90% at up to 63 days of gestation. The aim of this …

Objective To investigate the clinical efficacy of the combination of mifepristone and an orally
active prostaglandin, misoprostol, for early medical termination. Design Women with …

OBJECTIVE: To investigate the adjunctive use of mifepristone in second-trimester induction
abortions using misoprostol 1 day after feticidal digoxin. METHODS: This is a randomized …

BACKGROUND Home use of misoprostol for termination of pregnancy is still controversial in
many countries. Acceptability of home use of misoprostol has been investigated in …

Methods. A retrospective 2-year cohort study of 127 women, with gestation between 13 and
24 weeks and a live fetus, seeking induced abortion. The aim was to compare the effect of a …

Objective The effectiveness and safety of misoprostol have been reported for abortion up to
22 weeks' gestation. The objective of this study was to demonstrate the effectiveness and …

Objectives To demonstrate the effectiveness and safety of misoprostol without the need of
postexpulsion systematic curettage in early second-trimester abortions, ie at 13–15 weeks' …

Background Medical termination of pregnancy can be successfully performed with a
combination of mifepristone (RU 486) and a prostaglandin analogue. We conducted a …